ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,812, issued on July 8, was assigned to Georgia State University Research Foundation Inc. (Atlanta).
"Recombinant oncolytic virus" was invented by Ming Luo (Atlanta).
According to the abstract* released by the U.S. Patent & Trademark Office: "Recombinant viral vectors are disclosed that contain a nucleic acid encoding a Second Mitochondria-derived Activator of Caspases (Smac) protein inserted within an RNA virus genome, wherein the Smac protein specifically binds to at least a portion of an Inhibitor of Apoptosis Protein (IAP). Also disclosed are methods of treating cancer using the disclosed vectors."
The patent was filed on May 16, 2018, under Application No. 16/614,441.
*For f...